September 2016

Problematic AOD use is linked to many forms of chronic and life threatening conditions.

September 2016

NCETA is collaborating with researchers at QUT to undertake a workforce development study.

September 2016

NCETA is undertaking a detailed examination of patterns of AOD use to inform South Australian Primary Health Networks’ (PHN) planning and programs.

September 2016

This project will estimate the social and economic costs related to tobacco use in NSW for 2014.  Mortality and morbidity costs attributable to smo

September 2016

This project, commissioned by the Queensland Mental Health Commission, aims to identify effective ways of reducing stigma and discrimination which

June 2016

The use of so-called ‘study drugs’ or cognitive enhancers by students and workers has been receiving increased media attention in recent weeks. Study drugs are substances that are used in an attempt to improve intellectual ability in areas such as alertness, information processing and memory.

June 2016

NCETA is collaborating on a monograph with a team from the National Drug Research Institute (NDRI), the National Drug and Alcohol Research Centre (NDARC) and the South Australian Centre for Economic Studies (SACEC) to identify the societal costs of methamphetamine use in Australia.

June 2016

NCETA is conducting a literature review on behalf of the Network of Alcohol and Drug Agencies (NADA) to examine and evaluate information about the health and wellbeing of the alcohol and other drugs (AOD) workforce.

June 2016

This cluster randomised controlled trial examines a sustainable approach to enhance uptake of evidence-based care for unhealthy alcohol use in primary health care services targeting Indigenous Australians. It utilises a collaborative approach to select and implement service-wide changes to optimise care. The effectiveness of the service-wide intervention will then be assessed by routinely downloaded data on implementation of screening and treatment, including pharmacotherapies. Any changes in consumption will be described.

June 2016

This new project aims to examine the safety and efficacy of lisdexamfetamine in the treatment of adults with severe methamphetamine (MA) dependence. The study is the first controlled trial of maintenance lisdexamfetamine for the treatment of severe methamphetamine dependence, with major clinical and public health implications.

Pages